ValiRx interim loss widens as costs increase; hails Inaphaea progress
ValiRx PLC on Thursday reported an increased half-year loss amid higher costs, as it continued to focus on building its science-focused portfolio. The Essex, England-based life science company...
Source: marketscreener.com